Tech Company Financing Transactions

Leyden Labs Funding Round

ClavystBio, Polaris Partners and Casdin Capital participated in a $70 million funding round for Leyden Labs. The round was announced on 1/9/2025.

Transaction Overview

Company Name
Leyden Labs
Announced On
1/9/2025
Transaction Type
Venture Equity
Amount
$70,000,000
Round
Undisclosed
Investors

ClavystBio (Lead Investor)

Polaris Partners (Lead Investor)

Casdin Capital (Eli Casdin)

GV (David Schenkein)

Qiming Venture Partners USA

Proceeds Purpose
The company intends to use the funds to support further development of its pipeline aimed at providing protection against respiratory viruses, such as influenza and coronaviruses.

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
Keizersgracht 290 A
Amsterdam, 1016 EW
The Netherlands
Phone
Undisclosed
Website
www.leydenlabs.com
Email Address
[email protected]
Overview
Leyden Labs aims to help people live their lives to the fullest. Its platform targets commonalities of viral families to protect humanity from known and future viruses.
Profile
Leyden Labs LinkedIn Company Profile
Social Media
Leyden Labs Company Twitter Account
Company News
Leyden Labs News
Facebook
Leyden Labs on Facebook
YouTube
Leyden Labs on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Koenraad Wiedhaup
  Koenraad Wiedhaup LinkedIn Profile  Koenraad Wiedhaup Twitter Account  Koenraad Wiedhaup News  Koenraad Wiedhaup on Facebook
Chief Scientific Officer
Jaap Goudsmit
  Jaap Goudsmit LinkedIn Profile  Jaap Goudsmit Twitter Account  Jaap Goudsmit News  Jaap Goudsmit on Facebook
Controller
Lotte van Alst
  Lotte van Alst LinkedIn Profile  Lotte van Alst Twitter Account  Lotte van Alst News  Lotte van Alst on Facebook
VP - Bus. Development
Ronald Brus
  Ronald Brus LinkedIn Profile  Ronald Brus Twitter Account  Ronald Brus News  Ronald Brus on Facebook
VP - Bus. Development
Suha Jhaveri
  Suha Jhaveri LinkedIn Profile  Suha Jhaveri Twitter Account  Suha Jhaveri News  Suha Jhaveri on Facebook
VP - Bus. Development
Willemijn Kremer
  Willemijn Kremer LinkedIn Profile  Willemijn Kremer Twitter Account  Willemijn Kremer News  Willemijn Kremer on Facebook
VP - General Counsel
Albert Jan van Soelen
  Albert Jan van Soelen LinkedIn Profile  Albert Jan van Soelen Twitter Account  Albert Jan van Soelen News  Albert Jan van Soelen on Facebook
VP - Operations
Marieke van der Lans
  Marieke van der Lans LinkedIn Profile  Marieke van der Lans Twitter Account  Marieke van der Lans News  Marieke van der Lans on Facebook
VP - R & D
Galit Alter
  Galit Alter LinkedIn Profile  Galit Alter Twitter Account  Galit Alter News  Galit Alter on Facebook

 

 

Browse more venture capital transactions:

Prev: 1/9/2025: Coave Therapeutics venture capital transaction
Next: 1/9/2025: XOCEAN venture capital transaction

 

Share this article

 

Where The Data Comes From

We report on all VC transactions involving tech companies. VC investment data records on this site are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary

 

Copyright © 2001-2025. Gaebler Ventures. All rights reserved.